Literature DB >> 25083078

Epidemiology of fatty liver: an update.

Giorgio Bedogni1, Valerio Nobili1, Claudio Tiribelli1.   

Abstract

We provide a concise review of the main epidemiological literature on fatty liver (FL) published between January 2011 and October 2013. The findings from the literature will be considered in light of the already available knowledge. We discuss the limitations inherent in the categorization of FL into non-alcoholic and alcoholic FL, the potential relevance of FL as an independent predictor of cardiometabolic disease, and recent research addressing the role of FL as an independent predictor of mortality. This review is organized as a series of answers to relevant questions about the epidemiology of FL.

Entities:  

Keywords:  Epidemiology; Fatty liver

Mesh：

Year:  2014        PMID： 25083078      PMCID： PMC4112887          DOI： 10.3748/wjg.v20.i27.9050

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  54 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

2.  Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability.

Authors:  V Ratziu; E Bugianesi; J Dixon; E Fassio; M Ekstedt; F Charlotte; S Kechagias; T Poynard; R Olsson
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

3.  MR spectroscopy of the liver: principles and clinical applications.

Authors:  Aliya Qayyum
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

Review 4.  Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.

Authors:  Nazim Ghouri; David Preiss; Naveed Sattar
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.

Authors:  Amalia Gastaldelli; Michaela Kozakova; Kurt Højlund; Allan Flyvbjerg; Angela Favuzzi; Asimina Mitrakou; Beverley Balkau
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

6.  The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation.

Authors:  R K Simmons; K G M M Alberti; E A M Gale; S Colagiuri; J Tuomilehto; Q Qiao; A Ramachandran; N Tajima; I Brajkovich Mirchov; A Ben-Nakhi; G Reaven; B Hama Sambo; S Mendis; G Roglic
Journal:  Diabetologia       Date:  2009-12-11       Impact factor: 10.122

7.  Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).

Authors:  Thierry Poynard; Pascal Lebray; Patrick Ingiliz; Anne Varaut; Brigitte Varsat; Yen Ngo; Pascal Norha; Mona Munteanu; Fabienne Drane; Djamila Messous; Françoise Imbert Bismut; Jean Pierre Carrau; Julien Massard; Vlad Ratziu; Jean Pierre Giordanella
Journal:  BMC Gastroenterol       Date:  2010-04-22       Impact factor: 3.067

8.  Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.

Authors:  Beverley Balkau; Celine Lange; Sylviane Vol; Frederic Fumeron; Fabrice Bonnet
Journal:  BMC Gastroenterol       Date:  2010-06-07       Impact factor: 3.067

Review 9.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

Authors:  Curtis K Argo; Patrick G Northup; Abdullah M S Al-Osaimi; Stephen H Caldwell
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

10.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.

Authors:  Donghee Kim; W Ray Kim; Hwa Jung Kim; Terry M Therneau
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425
View more
  36 in total

1.  Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.

Authors:  Hongmei Zhang; Yixin Niu; Hongxia Gu; Shuai Lu; Weiwei Zhang; Xiaoyong Li; Zhen Yang; Li Qin; Qing Su
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

2.  Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.

Authors:  Yali Qu; Michael S Middleton; Rohit Loomba; Kevin J Glaser; Jun Chen; Jonathan C Hooker; Tanya Wolfson; Yesenia Covarrubias; Mark A Valasek; Kathryn J Fowler; Yingzhen N Zhang; Ethan Sy; Anthony C Gamst; Kang Wang; Adrija Mamidipalli; Jeffrey B Schwimmer; Bin Song; Scott B Reeder; Meng Yin; Richard L Ehman; Claude B Sirlin
Journal:  Eur Radiol       Date:  2021-04-26       Impact factor: 5.315

3.  Associations between dietary factors and markers of NAFLD in a general Dutch adult population.

Authors:  A Rietman; D Sluik; E J M Feskens; F J Kok; M Mensink
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

4.  Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.

Authors:  Javier De Luca-Johnson; Kirk J Wangensteen; Joshua Hanson; Edward Krawitt; Rebecca Wilcox
Journal:  Dig Dis Sci       Date:  2016-06-04       Impact factor: 3.199

Review 5.  Liver fat quantification: where do we stand?

Authors:  Jitka Starekova; Scott B Reeder
Journal:  Abdom Radiol (NY)       Date:  2020-10-06

6.  Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.

Authors:  Peter M Graffy; Veit Sandfort; Ronald M Summers; Perry J Pickhardt
Journal:  Radiology       Date:  2019-09-17       Impact factor: 11.105

7.  Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis.

Authors:  Yali Qu; Mou Li; Gavin Hamilton; Yingzhen N Zhang; Bin Song
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

8.  Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria.

Authors:  Carolina Castro Porto Silva Janovsky; Fernando H Cesena; Viviane Arevalo Tabone Valente; Raquel Dilguerian de Oliveira Conceição; Raul D Santos; Márcio Sommer Bittencourt
Journal:  Eur Thyroid J       Date:  2018-08-29

Review 9.  Comorbidities and Metabolic Derangement of NAFLD.

Authors:  Ki Bae Bang; Yong Kyun Cho
Journal:  J Lifestyle Med       Date:  2015-03-30

10.  Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis.

Authors:  Chunfang Xu; Zhenguo Qiao; Yongda Lu; Deqing Zhang; Zhenyu Jia; Xiaohui Zhuang; Yuqi Shi; Ting Xu; Lihua Xing; Jiaqing Shen
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.